Fig. 1: Outcome after second HAPLO-SCT in 82 patients with acute leukaemia.

RI relapse incidence, NRM non-relapse mortality, LFS leukaemia-free survival, OS overall survival.

RI relapse incidence, NRM non-relapse mortality, LFS leukaemia-free survival, OS overall survival.